Ignite Creation Date:
2024-05-06 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 2:27 PM
Study NCT ID:
NCT05276973
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2022-03-11
Brief Title:
Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment Paclitaxel and Carboplatin for Stage III or IV Epithelial Ovarian Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-08
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-03-11
First Submit QC Date:
March 11 2022
Study First Post Date:
2022-03-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-14
Last Update Post Date:
2024-07-03
Last Update Post Date Type:
ACTUAL